Annual Total Long Term Liabilities
$172.42 M
-$48.87 M-22.08%
December 31, 2023
Summary
- As of February 8, 2025, AKBA annual total long term liabilities is $172.42 million, with the most recent change of -$48.87 million (-22.08%) on December 31, 2023.
- During the last 3 years, AKBA annual total long term liabilities has fallen by -$36.96 million (-17.65%).
- AKBA annual total long term liabilities is now -22.08% below its all-time high of $221.29 million, reached on December 31, 2022.
Performance
AKBA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$191.84 M
+$45.19 M+30.81%
September 30, 2024
Summary
- As of February 8, 2025, AKBA quarterly total long term liabilities is $191.84 million, with the most recent change of +$45.19 million (+30.81%) on September 30, 2024.
- Over the past year, AKBA quarterly long term liabilities has increased by +$45.19 million (+30.81%).
- AKBA quarterly long term liabilities is now -30.47% below its all-time high of $275.91 million, reached on September 30, 2021.
Performance
AKBA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AKBA Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -22.1% | +30.8% |
3 y3 years | -17.6% | -1.3% |
5 y5 years | +81.7% | -1.3% |
AKBA Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -22.1% | at low | -24.9% | +30.8% |
5 y | 5-year | -22.1% | +2.4% | -30.5% | +30.8% |
alltime | all time | -22.1% | -100.0% | -30.5% | >+9999.0% |
Akebia Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $191.84 M(+30.8%) |
Jun 2024 | - | $146.65 M(-21.3%) |
Mar 2024 | - | $186.25 M(+8.0%) |
Dec 2023 | $172.42 M(-22.1%) | $172.42 M(-11.5%) |
Sep 2023 | - | $194.72 M(+3.4%) |
Jun 2023 | - | $188.34 M(-9.6%) |
Mar 2023 | - | $208.27 M(-5.9%) |
Dec 2022 | $221.29 M(+13.9%) | $221.29 M(-5.5%) |
Sep 2022 | - | $234.08 M(+3.7%) |
Jun 2022 | - | $225.82 M(-11.6%) |
Mar 2022 | - | $255.33 M(+31.4%) |
Dec 2021 | $194.29 M(-7.2%) | $194.29 M(-29.6%) |
Sep 2021 | - | $275.91 M(+1.6%) |
Jun 2021 | - | $271.64 M(+12.2%) |
Mar 2021 | - | $242.13 M(+15.6%) |
Dec 2020 | $209.38 M(+24.4%) | $209.38 M(+18.5%) |
Sep 2020 | - | $176.72 M(-1.3%) |
Jun 2020 | - | $179.14 M(+1.1%) |
Mar 2020 | - | $177.20 M(+5.3%) |
Dec 2019 | $168.33 M | $168.33 M(+61.1%) |
Sep 2019 | - | $104.51 M(-11.8%) |
Jun 2019 | - | $118.55 M(-2.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $121.80 M(+28.3%) |
Dec 2018 | $94.92 M(-5.6%) | $94.92 M(+13.2%) |
Sep 2018 | - | $83.89 M(+0.5%) |
Jun 2018 | - | $83.44 M(-11.4%) |
Mar 2018 | - | $94.20 M(-6.3%) |
Dec 2017 | $100.57 M(-14.6%) | $100.57 M(+15.1%) |
Sep 2017 | - | $87.36 M(-11.1%) |
Jun 2017 | - | $98.23 M(+3.2%) |
Mar 2017 | - | $95.18 M(-19.2%) |
Dec 2016 | $117.83 M(>+9900.0%) | $117.83 M(+178.8%) |
Sep 2016 | - | $42.27 M(+2.1%) |
Jun 2016 | - | $41.41 M(+2.8%) |
Mar 2016 | - | $40.27 M(>+9900.0%) |
Dec 2015 | $74.00 K(+131.3%) | $74.00 K(+640.0%) |
Sep 2015 | - | $10.00 K(0.0%) |
Jun 2015 | - | $10.00 K(+11.1%) |
Mar 2015 | - | $9000.00(-71.9%) |
Dec 2014 | $32.00 K(+300.0%) | $32.00 K(-5.9%) |
Sep 2014 | - | $34.00 K(-5.3%) |
Jun 2014 | - | $35.90 K(-5.0%) |
Mar 2014 | - | $37.80 K(+372.5%) |
Dec 2013 | $8000.00(>+9900.0%) | $8000.00 |
Dec 2012 | $0.00 | - |
FAQ
- What is Akebia Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Akebia Therapeutics?
- What is Akebia Therapeutics annual total long term liabilities year-on-year change?
- What is Akebia Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly long term liabilities year-on-year change?
What is Akebia Therapeutics annual total long term liabilities?
The current annual total long term liabilities of AKBA is $172.42 M
What is the all time high annual total long term liabilities for Akebia Therapeutics?
Akebia Therapeutics all-time high annual total long term liabilities is $221.29 M
What is Akebia Therapeutics annual total long term liabilities year-on-year change?
Over the past year, AKBA annual total long term liabilities has changed by -$48.87 M (-22.08%)
What is Akebia Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of AKBA is $191.84 M
What is the all time high quarterly long term liabilities for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly total long term liabilities is $275.91 M
What is Akebia Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, AKBA quarterly total long term liabilities has changed by +$45.19 M (+30.81%)